Vision Screening Assessment (VISA) tool: diagnostic accuracy validation of a novel screening tool in detecting visual impairment among stroke survivors



Rowe, Fiona J ORCID: 0000-0001-9210-9131, Hepworth, Lauren ORCID: 0000-0001-8542-9815, Howard, Claire, Bruce, Alison, Smerdon, Victoria, Payne, Terry ORCID: 0000-0002-0106-8731, Jimmieson, Phil ORCID: 0000-0003-3732-970X and Burnside, Girvan ORCID: 0000-0001-7398-1346
(2020) Vision Screening Assessment (VISA) tool: diagnostic accuracy validation of a novel screening tool in detecting visual impairment among stroke survivors. BMJ open, 10 (6).

[img] Text
Vision.pdf - OA Published Version

Download (438kB) | Preview

Abstract

PURPOSE:Screening for visual problems in stroke survivors is not standardised. Visual problems that remain undetected or poorly identified can create unmet needs for stroke survivors. We report the validation of a new Vision Impairment Screening Assessment (VISA) tool intended for use by the stroke team to improve identification of visual impairment in stroke survivors. METHODS:We conducted a prospective case cohort comparative study in four centres to validate the VISA tool against a specialist reference vision assessment. VISA is available in print or as an app (Medicines and Healthcare products Regulatory Agency regulatory approved); these were used equally for two groups. Both VISA and the comprehensive reference vision assessment measured case history, visual acuity, eye alignment, eye movements, visual field and visual inattention. The primary outcome measure was the presence or absence of visual impairment. RESULTS:Two hundred and twenty-one stroke survivors were screened. Specialist reference vision assessment was by experienced orthoptists. Full completion of screening and reference vision assessment was achieved for 201 stroke survivors. VISA print was completed for 101 stroke survivors; VISA app was completed for 100. Sensitivity and specificity of VISA print was 97.67% and 66.67%, respectively. Overall agreement was substantial; K=0.648. Sensitivity and specificity of VISA app was 88.31% and 86.96%, respectively. Overall agreement was substantial; K=0.690. Lowest agreement was found for screening of eye movement and near visual acuity. CONCLUSIONS:This validation study indicates acceptability of VISA for screening of potential visual impairment in stroke survivors. Sensitivity and specificity were high indicating the accuracy of this screening tool. VISA is available in print or as an app allowing versatile uptake across multiple stroke settings.

Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 26 Jun 2020 07:58
Last Modified: 08 Oct 2021 11:54
DOI: 10.1136/bmjopen-2019-033639
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3091690